- Home
- CRNX vs NOVT Comparison
CRNX vs NOVT Comparison
Compare CRNX & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- NOVT
- Stock Information
- Founded
- CRNX 2008
- NOVT 1968
- Country
- CRNX United States
- NOVT United States
- Employees
- CRNX N/A
- NOVT N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- NOVT Industrial Machinery/Components
- Sector
- CRNX Health Care
- NOVT Miscellaneous
- Exchange
- CRNX Nasdaq
- NOVT Nasdaq
- Market Cap
- CRNX 5.2B
- NOVT 5.1B
- IPO Year
- CRNX 2018
- NOVT N/A
- Fundamental
- Price
- CRNX $37.46
- NOVT $140.51
- Analyst Decision
- CRNX Strong Buy
- NOVT Hold
- Analyst Count
- CRNX 12
- NOVT 1
- Target Price
- CRNX $72.64
- NOVT $169.00
- AVG Volume (30 Days)
- CRNX 747.4K
- NOVT 191.5K
- Earning Date
- CRNX 02-27-2025
- NOVT 02-25-2025
- Dividend Yield
- CRNX N/A
- NOVT N/A
- EPS Growth
- CRNX N/A
- NOVT N/A
- EPS
- CRNX N/A
- NOVT 1.66
- Revenue
- CRNX $1,038,999.00
- NOVT $922,754,000.00
- Revenue This Year
- CRNX N/A
- NOVT $10.08
- Revenue Next Year
- CRNX $206.01
- NOVT $9.43
- P/E Ratio
- CRNX N/A
- NOVT $84.63
- Revenue Growth
- CRNX N/A
- NOVT 3.86
- 52 Week Low
- CRNX $34.07
- NOVT $139.78
- 52 Week High
- CRNX $62.53
- NOVT $187.12
- Technical
- Relative Strength Index (RSI)
- CRNX 42.29
- NOVT 33.04
- Support Level
- CRNX $35.10
- NOVT $140.53
- Resistance Level
- CRNX $35.85
- NOVT $145.23
- Average True Range (ATR)
- CRNX 1.45
- NOVT 3.66
- MACD
- CRNX 0.47
- NOVT -0.26
- Stochastic Oscillator
- CRNX 49.78
- NOVT 6.82
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.